0512-67998899(Suzhou)
0755-89997436(Shenzhen)
Pipeline Code
|
Adaptability
|
Target
|
Technology Platform
|
Proof of Concept
|
Animal Experiment
|
IIT
|
IND
|
Comparison
|
BM-1901
|
腹腔转移HER2阳性实体瘤
|
HER2
|
24H
|
鲲石生物科技 徐州医科大学附属医院 |
First in class
|
|||
BM-1902
|
脑胶质瘤
|
***
|
24H
|
|
First in class
|
|||
BM-1903
|
胰腺癌
|
***
|
24H
|
|
First in class
|
|||
BM-1904
|
肝癌
|
***
|
24H
|
|
First in class
|
|||
BM-1905
|
肺癌
|
***
|
24H
|
|
First in class
|
|||
BM-1906
|
系统性红斑狼疮
|
***
|
24H
|
鲲石生物科技 南京鼓楼医院 |
First in class
|
|||
DM-2001
|
肺纤维化
|
***
|
24H
|
|
First in class
|
|||
DM-2002
|
肺纤维化
|
***
|
24H
|
|
First in class
|
0512-67998899(Suzhou)
0755-89997436(Shenzhen)
Cathy.Lv@rocrockbio.com(Suzhou)
lliangjing@rocrockbio.com (Shenzhen)